Bristol Myers Squibb has become the latest Big Pharma to tie up a biotech pact as we reach the year’s end, tapping Harbour ...

This new capability gives advertisers seamless access to the interactive ad format directly through their DSP of choice ...

A flurry of deal-making hasn’t let up as 2025 comes to a close, with Roche subsidiary Genentech getting in on the action and ...

The competition between Netflix and Paramount Skydance to acquire the studio is haunted by the ghosts of mergers past.

In the last Fierce Pharma Asia weekly news roundup of 2025, Daiichi Sankyo scored a key FDA approval for ...

The grace period is over. 12 predictions on where AI creates value, breaks assumptions, and triggers backlash as 2026 becomes ...

There’s a hair more than two weeks left in 2025, and that means it’s time for that hoary old journalistic tradition: Lists.

New collaboration builds on Sanofi’s prior acquisition of DR-0201 and further leverages Dren Bio’s proprietary Targeted Myeloid Engager and Phagocyt ...

Explore eight major immunology and inflammation (I&I) partnerships in 2025, from early-stage research to late-stage licensing ...

Trump Media announces an all-stock merger with TAE Technologies, pivoting radically from media to fusion energy optionality.

Launched on 17 December 2025, the update followed the recent debut of GPT-5.2 and aimed to reclaim momentum from Google ...

The U.S. Space Force is looking for advanced technologies for space-based interceptors that can intercept ballistic missiles ...